Hexagon Nutrition Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹2.75(6.11%)
Premium (ELP)
Following its successful public offering, Hexagon Nutrition Limited's made its market debut on Jun 12, 2026 and is now actively traded on the NSE, BSEplatform. The IPO mobilized 3,08,59,704 Shares in total capital, including TBD in primary equity infusion and ₹138.87 Cr in secondary share sales.
The offering was structured with a price band of ₹42 to ₹45 and minimum investment lots of 333 shares. Investor participation during the subscription window from Jun 05, 2026 to Jun 09, 2026 demonstrated market confidence in the company's prospects.
The allotment process concluded on Jun 10, 2026, allocating shares to successful bidders. The listing represents the culmination of the IPO process, transitioning the company to publicly traded status with enhanced transparency and governance standards.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Hexagon Nutrition Ltd., established in 1993, is a research-based nutrition company that develops and manufactures a wide range of products including micronutrient premixes, wellness and clinical nutrition products, therapeutic formulations, and ready-to-use foods. The company operates three manufacturing units in India at Nasik, Chennai, and Thoothukudi, along with an international facility in Tashkent, Uzbekistan, with two Indian units located in SEZ areas for better logistics and cost benefits. Its products are divided into three main segments: consumer nutrition products, premix solutions for businesses, and ready-to-use nutrition products under ESG initiatives. The company has a strong distribution network across India through pharmacies, hospitals, e-commerce platforms, and its own brands, supported by over 342 distributors. It also has international offices in South Africa, Uzbekistan, and Hong Kong, exporting products to more than 75 countries. With dedicated R&D facilities and a team of professionals, the company focuses on innovation, and as of July 2025, it has a workforce of 482 employees.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Strong Global Presence : Exports to 75+ countries with international offices, ensuring diversified revenue streams.
- Research-Driven Product Portfolio : Focus on R&D enables innovative nutrition and therapeutic products.
- Wide Distribution Network : Strong reach through pharmacies, hospitals, e-commerce, and 300+ distributors.
- Regulatory Compliance Risk : Nutrition and healthcare products are subject to strict regulations across markets.
- High Competition in Nutrition Industry : Faces competition from global and domestic healthcare and FMCG players.
- Dependence on Raw Materials : Fluctuations in input costs can impact margins and profitability.
- Arun Purushottam Kelkar
- Subhash Purushottam Kelkar
- Vikram Arun Kelkar
- Nikhil Arun Kelkar
Hexagon Nutrition Limited
Kfin Technologies Limited